MyMD Shares Surge on Positive Sarcopenia Study Results MYMD
MYMDDelisted Stock | USD 1.82 0.02 1.09% |
About 62% of MYMD Old's investor base is looking to short. The analysis of current outlook of investing in MYMD Old suggests that many traders are alarmed regarding MYMD Old's prospects. The current market sentiment, together with MYMD Old's historical and current headlines, can help investors time the market. In addition, many technical investors use MYMD Old stock news signals to limit their universe of possible portfolio assets.
MYMD |
By Colin Kellaher MyMD Pharmaceuticals shares rose sharply Monday after the clinical-stage pharmaceutical company reported positive results from a Phase 2...
Read at marketwatch.com
MYMD Old Fundamental Analysis
We analyze MYMD Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MYMD Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MYMD Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
MYMD Old is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
MYMD Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MYMD Old stock to make a market-neutral strategy. Peer analysis of MYMD Old could also be used in its relative valuation, which is a method of valuing MYMD Old by comparing valuation metrics with similar companies.
Peers
MYMD Old Related Equities
NBY | NovaBay Pharmaceuticals | 8.57 | ||||
ORIC | Oric Pharmaceuticals | 8.04 | ||||
XBIO | Xenetic Biosciences | 5.70 | ||||
SRZN | Surrozen | 1.52 | ||||
LGND | Ligand Pharmaceuticals | 0.40 | ||||
KRON | Kronos Bio | 1.04 | ||||
REPL | Replimune | 1.54 | ||||
LYEL | Lyell Immunopharma | 1.67 | ||||
BOLT | Bolt Biotherapeutics | 1.85 | ||||
RXRX | Recursion Pharmaceuticals | 2.03 | ||||
AVIR | Atea Pharmaceuticals | 2.14 | ||||
KZR | Kezar Life | 3.23 | ||||
UBX | Unity Biotechnology | 3.91 | ||||
PASG | Passage Bio | 4.48 | ||||
LRMR | Larimar Therapeutics | 4.92 | ||||
GOVX | GeoVax Labs | 4.93 | ||||
GOSS | Gossamer Bio | 5.15 | ||||
REVB | Revelation Biosciences | 5.66 | ||||
NVCT | Nuvectis Pharma | 5.83 | ||||
DSGN | Design Therapeutics | 9.07 | ||||
LYRA | Lyra Therapeutics | 9.09 | ||||
KROS | Keros Therapeutics | 11.95 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Consideration for investing in MYMD Stock
If you are still planning to invest in MYMD Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MYMD Old's history and understand the potential risks before investing.
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |